Indian Villages Considered 'Cash Machine' For Global Pharmas
This article was originally published in PharmAsia News
Executive Summary
India's rural population is attracting Novartis and Sanofi-Aventis, acting separately, both seeking to cash in on the nation's $19.5 billion plan for improving public healthcare